⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INMB News
INmune Bio Inc. Common stock
INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th
globenewswire.com
INMB
INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models
globenewswire.com
INMB
INmune Bio Inc. Announces 2025 Results and Provides Business Update
globenewswire.com
INMB
INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.
globenewswire.com
INMB
INmune Bio’s MINDFuL Trial Featured at AD/PD 2026 Plenary as Successful Example of How to Approach Clinical Trials Targeting Inflammation in Early Alzheimer’s Disease
globenewswire.com
INMB
Form 8-K
sec.gov
INMB
Form 8-K
sec.gov
INMB
INmune Bio to Detail XPro1595 Registrational Strategy in Upcoming Alzheimer’s Webinar
globenewswire.com
INMB
Form 8-K
sec.gov
INMB
INmune Bio Announces Upcoming Webinar to Present New Clinical Data on CORDStrom™ for RDEB
globenewswire.com
INMB